Maria Aguilar-Diez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Evaluation of carbapenem inactivation method-based phenotypic assays for the detection of GES-type carbapenemases in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii.
Journal: Journal of clinical microbiology
Published: August 21, 2026
Emergence of carbapenemase KPC-14 in an Escherichia coli isolate: a case report.
Journal: JAC-antimicrobial resistance
Published: August 06, 2026
Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections.
Journal: Antimicrobial agents and chemotherapy
Published: October 21, 2024
Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences.
Journal: Frontiers in cellular and infection microbiology
Published: June 10, 2024
Whole-genome analysis of Haemophilus influenzae strains isolated from persons with cystic fibrosis.
Journal: Journal of medical microbiology
Published: August 25, 2022
Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae.
Journal: Acta microbiologica et immunologica Hungarica
Published: May 21, 2022
Establishing Antimicrobial Susceptibility Testing Methods and Clinical Breakpoints for Inhaled Antibiotic Therapy.
Journal: Open forum infectious diseases
Published: November 29, 2021
Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.
Journal: The Journal of antimicrobial chemotherapy
Published: April 13, 2021
Evaluation of Rapid Polymyxin Pseudomonas test in clinical Pseudomonas aeruginosa isolates with various degrees of multidrug resistance.
Journal: JAC-antimicrobial resistance
Published: March 20, 2021
Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates.
Journal: The Journal of antimicrobial chemotherapy
Published: October 02, 2020
Whole-genome analysis of Pandoraea species strains from cystic fibrosis patients.
Journal: Future microbiology
Published: November 26, 2019
Draft genome sequence of the strain 16-537536, isolated from a patient with bronchiectasis and its relationship to the Pseudomonas koreensis group of the Pseudomonas fluorescens complex.
Journal: BMC research notes
Published: October 18, 2019
Last Updated: 09/26/2026